Lyganex Bio Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Lyganex Bio General Information
Description
Developer of small molecule drugs that increase plasticity within tissue lesion sites after injury. The company's novel therapy when applied topically and systemically promotes natural tissue regeneration, heals wound and minimizes scar formation.
Contact Information
Corporate Office
- 3260 Edinwick Way
- Columbus, OH 43232
- United States
Corporate Office
- 3260 Edinwick Way
- Columbus, OH 43232
- United States
Lyganex Bio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lyganex Bio FAQs
-
When was Lyganex Bio founded?
Lyganex Bio was founded in 2016.
-
Where is Lyganex Bio headquartered?
Lyganex Bio is headquartered in Columbus, OH.
-
What industry is Lyganex Bio in?
Lyganex Bio’s primary industry is Drug Discovery.
-
Is Lyganex Bio a private or public company?
Lyganex Bio is a Private company.
-
What is Lyganex Bio’s current revenue?
The current revenue for Lyganex Bio is .
-
Who acquired Lyganex Bio?
Lyganex Bio was acquired by RiverTown Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process